Search

Your search keyword '"Singhal, Naman"' showing total 8 results
Start Over Author "Singhal, Naman"
8 results on '"Singhal, Naman"'

1. Water quality prediction using deep learning.

Author

Pawar, Parth, Singhal, Naman, and Sahayaraj, K. Kishore Anthuvan

Subjects
*WATER quality, *CONVOLUTIONAL neural networks, *DEEP learning, *WATER supply
Abstract

Water quality prediction has a crucial significance in ensuring the safety and usability of water resources. In this paper, we propose a CNN with BiLSTM model for accurate water quality prediction. The model combines convolutional neural network layers with BiLSTM to effectively capture the spatio-temporal dependencies present in the data. Experimental results on the water quality dataset demonstrate the superior performance of the proposed model. The model achieves a validation accuracy of 92.83%. These results surpass those obtained by other models such as GRU, LSTM, and CNN with LSTM. The CNN with BiLSTM model's ability to effectively learn and classify water samples based on provided features highlights its potential for reliable water quality prediction. This paper contributes to the field of water quality prediction by providing a robust model that can aid in ensuring the safety and suitability of water resources. [ABSTRACT FROM AUTHOR]

Published
2024
Full Text
View/download PDF

2. Smart Portable Neonatal Intensive Care for Rural Regions

Author

Lepcha, Samden, Jain, Suraj S., Kumar, Sonal, Puneeth, C, Singhal, Naman, Saw, Anurag Kumar, Batra, Abhijeet Singh, Shukla, Sameeksha, Unal, Aynur, Kacprzyk, Janusz, Series Editor, Gomide, Fernando, Advisory Editor, Kaynak, Okyay, Advisory Editor, Liu, Derong, Advisory Editor, Pedrycz, Witold, Advisory Editor, Polycarpou, Marios M., Advisory Editor, Rudas, Imre J., Advisory Editor, Wang, Jun, Advisory Editor, Fong, Simon, editor, Dey, Nilanjan, editor, and Joshi, Amit, editor

Published
2020
Full Text
View/download PDF

3. Smart Portable Neonatal Intensive Care for Rural Regions

Author

Lepcha, Samden, primary, Jain, Suraj S., additional, Kumar, Sonal, additional, Puneeth, C, additional, Singhal, Naman, additional, Saw, Anurag Kumar, additional, Batra, Abhijeet Singh, additional, Shukla, Sameeksha, additional, and Unal, Aynur, additional

Published
2020
Full Text
View/download PDF

4. Comparison of efficacy and safety of a combination of tamsulosin and mirabegron versus tamsulosin alone in the management of overactive bladder in males with lower urinary tract symptoms –TAME-overactive bladder: An open-labeled randomized controlled trial

Author

Anwar, Azhar, Gorka, Vivek, Chahal, Harmandeep, Sharma, Sandeep, Tandon, Sunit, Singhal, Naman, Narwade, Pankaj, Chauhan, Nikhil, Bansal, Namita, and Kaur, Simran

Subjects
OVERACTIVE bladder, TAMSULOSIN, BETA adrenoceptors, BLADDER, RANDOMIZED controlled trials, BENIGN prostatic hyperplasia
Abstract

Background: Overactive bladder (OAB) is a common condition in elderly men with coexisting benign prostatic enlargement (BPE), and it significantly impairs their quality of life (QoL). Aim: This study aimed to assess the safety and efficacy of adding beta-3 adrenergic receptor agonist (mirabegron 50 mg) to tamsulosin 0.4 mg for symptomatic men with BPE and OAB symptoms (OABS). Materials and Methods: It was an open-labeled randomized controlled trial. Ninety men with BPE and International Prostate Symptom Score (IPSS) of more than seven with predominant OABS were enrolled for the study. A detailed history, uroflowmetry, and baseline scores, including IPSS, OABS score (OABSS), and QoL assessment, were done for each patient. After written informed consent, patients were randomized into two groups of 45 each. Group-1 received tamsulosin 0.4 mg and placebo, and Group-2 received a combination of tamsulosin 0.4 mg plus mirabegron 50 mg once daily at bedtime. Follow-up of patients was done at 2nd, 4th, and 8th weeks. Efficacy at 8 weeks was assessed using repeat history for symptoms, uroflowmetry, IPSS, OABSS, and QoL score. Results: After 8 weeks of therapy, collected data were compared to baseline parameters in both groups. Significant improvement with respect to OABSS (P = 0.046), IPSS (P = 0.006), and QoL (P = 0.038) was observed with combination therapy versus tamsulosin alone. There were mild adverse effects, which were self-limiting. Conclusions: A combination of tamsulosin with mirabegron is effective and safe in improving the OABSS, IPSS, and QoL in men with BPE who have predominant OABS. [ABSTRACT FROM AUTHOR]

Published
2023
Full Text
View/download PDF

5. Pattern Prediction in Stock Market

Author

Kaushik, Saroj, Singhal, Naman, Hutchison, David, editor, Kanade, Takeo, editor, Kittler, Josef, editor, Kleinberg, Jon M., editor, Mattern, Friedemann, editor, Mitchell, John C., editor, Naor, Moni, editor, Nierstrasz, Oscar, editor, Pandu Rangan, C., editor, Steffen, Bernhard, editor, Sudan, Madhu, editor, Terzopoulos, Demetri, editor, Tygar, Doug, editor, Vardi, Moshe Y., editor, Weikum, Gerhard, editor, Goebel, Randy, editor, Siekmann, Jörg, editor, Wahlster, Wolfgang, editor, Nicholson, Ann, editor, and Li, Xiaodong, editor

Published
2009
Full Text
View/download PDF

Catalog

Books, media, physical & digital resources
See catalog results